Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
CRANKSTART AWARDS $7 MILLION GRANT TO FREEDOM WEST COMMUNITY DEVELOPMENT CORPORATION
-
Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream
-
Arcos Dorados Holdings Inc. First Quarter 2025 Results Webcast Date and Time
-
TSCG Credit Opportunities I, LLC Provides Preferred Equity for Tennessee Retail Development
-
Fully-integrated browser AI, Aria, is now available to millions of Opera Mini users
-
Altus Power Closes Transaction with TPG
-
Aya Gold & Silver Announces Completion of Strategic Transaction with Mx2 Mining
-
Strategic Investors Back Hammerspace as New Standard for AI Data Performance
-
Pismo names Vishal Dalal as CEO
-
CIBC Innovation Banking Serves as Lead Arranger of a Syndicated Debt Facility for Vena Solutions
-
AMC Empire 25 and AMC Lincoln Square 13 Wrap Up Multi-Million Dollar Seating Renovation Projects – Giving Guests Wider and More Comfortable Seating, With More Than 4,000 All-New AMC Club Rockers Ins
-
Special Needs Network Hosts 19th Annual Tools for Transformation Conference
-
Jersey Central Power & Light Company Announces Launch of Exchange Offer for its 5.100% Senior Notes Due 2035
-
Sierra Metals Reports First Quarter 2025 Production Results
-
Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer
-
AIRNA Appoints Jacob Elkins Chief Medical Officer
-
CRITEO TO ANNOUNCE FIRST QUARTER 2025 FINANCIAL RESULTS ON MAY 2, 2025
-
Fingerprint Reports 175% Revenue Growth and Platform Expansion as Demand for Enterprise Fraud Prevention Intensifies
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG
-
H Partners Launches Withhold Campaign to Remove Three Entrenched Directors of Harley-Davidson at 2025 Annual Meeting
-
Amwins Special Risk Underwriters Introduces Exclusive Excess Casualty Capabilities
-
New Mythbusting Grocery Sentiment Index Reveals Positive Outlook for US Shopper Spending in Global Grocery Industry
-
MEXC Announces Official Listing of PAWS (PAWS)
-
Catalyze Secures $85 Million Tax Equity Investment from RBC to Advance Distributed Energy Portfolio
-
CI Global Asset Management Launches Solana ETF with 0% Management Fee for First Three Months
-
Jeannette Eastin Awarded With “Excellence In Education Award” At Education 2.0 Conference USA Edition
-
Dr. Amanda Kenderes Honored With “Excellence In Education Award” At The Education 2.0 Conference USA Edition 2025
-
Altair Partners with Databricks to Accelerate Data-Driven Innovation
-
Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025
-
TruthSayer AI Launches the World’s First AI Hedge Fund-in-a-Box for Retail Investors
-
Entegris Declares Quarterly Cash Dividend
-
K2 Cyber Partners with TransUnion to Deliver Cybersecurity Protection and Services
-
Glaukos Announces the Release of its 2024 Sustainability Report
-
U.S. Energy Corp. Announces Acreage Acquisition and CCUS Development Update
-
United Therapeutics Corporation to Report First Quarter 2025 Financial Results Before Market Open on Wednesday, April 30, 2025
-
Purple Biotech Announces Publication in the Neuro Oncology Journal Demonstrating the Potential of NT219 to Suppress Brain Metastasis of Colorectal Cancer
-
The College of Commercial Arbitrators Reaffirms Commitment to the Rule of Law
-
Rivalry Reports Strong Q1 2025 KPI Growth, Validating Strategic Pivot Amid Temporary Margin Variance
-
Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025
-
INmune Bio Receives Favorable Patentability Opinion for CORDStrom™ Platform Technology
-
UgoWork strengthens its industry presence through a packed spring 2025 industry calendar
-
Tilray Brands Ranks #4 on the Brewers Association List of Top Producing Craft Brewers in the United States
-
OTC Markets Group Welcomes Sprott Physical Copper Trust to OTCQX
-
Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid A
-
AIR Education Experts Share Evidence at American Educational Research Association, National Council on Measurement in Education Annual Meetings
-
AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan
-
Q32 Bio Doses First Patients in Both Part A Open-Label Extension and Part B of SIGNAL-AA Phase 2a Trial Evaluating Bempikibart in Alopecia Areata
-
FXDyno's AI-Powered Wave Trading Set to Redefine Gold Trading
-
FXDyno's AI-Powered Wave Trading Set to Redefine Gold Trading

